
Genertec Universal Medical Group Company Limited
2666.HKHKSEFinancial ServicesFinancial - Credit Services
Latest quote
HK$4.605
−HK$0.065 · -1.39%
2666.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteGenertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare business. The company's operations are segmented into two primary divisions. The Finance and Advisory segment delivers a range of services including direct finance leasing, sale-and-leaseback arrangements, factoring, operating leases, and various advisory offerings. Meanwhile, its Hospital Group segment focuses on providing medical care, managing hospitals and healthcare facilities, and conducting import, export, and general trading of medical-related goods. Beyond these core areas, Genertec Universal Medical also engages in medical technology development, hospital digitalization, construction, and management services, as well as property management and medical consulting. The company serves a diverse clientele, encompassing patients, hospitals, medical equipment suppliers, and other public sector organizations. In July 2018, the company adopted its current name, having previously operated as Universal Medical Financial & Technical Advisory Services Company Limited.
- Industry
- Financial - Credit Services
- Sector
- Financial Services
- Headquarters
- CN
- CEO
- Qi Xia
- Listed since
- Jul 8, 2015
- Employees
- 23,791
Market position
Day range
Current HK$4.605
52-week range
Current HK$4.605
- Open
- HK$4.68
- Previous close
- HK$4.67
- Volume
- 3.61M
- 0.74× average
- Average volume
- 4.85M
- Average daily volume
- Market cap
- 9.28B HKD
- Beta
- 0.59
- Market reference 1
- 50-day average
- HK$4.7247
- -2.53% below average
- 200-day average
- HK$5.681
- -18.94% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 58.34B CNY
- P/E (TTM)
- 3.49×
- P/B (TTM)
- 0.42×
- P/S (TTM)
- 0.55×
- EV / EBITDA
- 15.05×
- Earnings yield
- 20.26%
- Free cash flow yield
- 28.28%
- Dividend yield
- 7.82%
Profitability & efficiency
- Gross margin
- 100.00%
- Operating margin
- 58.56%
- Net margin
- 15.19%
- Return on equity
- 11.45%
- Return on assets
- 2.62%
- Return on invested capital
- 11.52%
Financial health
- Debt / equity
- 2.6×
- Current ratio
- 3.64×
- Altman Z-score
- 1.65
- Piotroski F-score
- 7 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.54B CNY | 13.66B CNY | 13.65B CNY | 11.57B CNY | 9.57B CNY |
| Cost of goods sold | 9.59B CNY | 9.07B CNY | 9.08B CNY | 7.58B CNY | 5.71B CNY |
| Gross profit | 5.06B CNY | 4.59B CNY | 4.57B CNY | 11.73B CNY | 9.57B CNY |
| Research and development | 77.66M CNY | 66.78M CNY | 35.88M CNY | 48.07M CNY | 25.84M CNY |
| Selling, general, and administrative | 1.8B CNY | 1.71B CNY | 1.57B CNY | 1.36B CNY | 1.2B CNY |
| Operating expenses | 552.67M CNY | 1.51B CNY | 1.34B CNY | 1.15B CNY | 990.25M CNY |
| Interest income | 41.94M CNY | 55.51M CNY | 84.13M CNY | 73.96M CNY | 56.7M CNY |
| Interest expense | 69.35M CNY | 50.71M CNY | 39.05M CNY | 35.32M CNY | 29.13M CNY |
| Depreciation and amortization | 788.46M CNY | 602.26M CNY | 508.67M CNY | 442.05M CNY | 319.46M CNY |
| Operating income | 12.66B CNY | 3.09B CNY | 3.23B CNY | 10.33B CNY | 8.34B CNY |
| Net income | 2.21B CNY | 2.1B CNY | 2.11B CNY | 1.96B CNY | 1.95B CNY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 0%
- 0 beats, 4 misses, 0 met estimates
- Average EPS surprise
- -53.27%
- 4 comparable reports
- Latest EPS result
- 0.53
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.35
2025 complete year+12.9% since 2021
2026 partial: HK$0.36
HK$0.31
2,021
HK$0.36
2,022
HK$0.34
2,023
HK$0.35
2,024
HK$0.35
2,025
HK$0.36
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 26, 2026 | HK$0.36Annual | Jun 30, 2026 | Jul 15, 2026 |
Dividend | Jun 12, 2025 | HK$0.35Annual | Jun 14, 2025 | Jun 27, 2025 |
Dividend | Jun 12, 2024 | HK$0.35Annual | Jun 13, 2024 | Jul 30, 2024 |
Dividend | Jun 9, 2023 | HK$0.34Annual | Jun 12, 2023 | Jun 27, 2023 |
Dividend | Jun 9, 2022 | HK$0.36Annual | Jun 10, 2022 | Jun 27, 2022 |
Dividend | Jun 10, 2021 | HK$0.31Annual | Jun 11, 2021 | Jun 28, 2021 |
Ex-dividend Jun 26, 2026
HK$0.36
Annual
Record Jun 30, 2026 · Payment Jul 15, 2026
Ex-dividend Jun 12, 2025
HK$0.35
Annual
Record Jun 14, 2025 · Payment Jun 27, 2025
Ex-dividend Jun 12, 2024
HK$0.35
Annual
Record Jun 13, 2024 · Payment Jul 30, 2024
Ex-dividend Jun 9, 2023
HK$0.34
Annual
Record Jun 12, 2023 · Payment Jun 27, 2023
Ex-dividend Jun 9, 2022
HK$0.36
Annual
Record Jun 10, 2022 · Payment Jun 27, 2022
Ex-dividend Jun 10, 2021
HK$0.31
Annual
Record Jun 11, 2021 · Payment Jun 28, 2021
2666.HK peers
ETFs holding 2666.HK
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard FTSE Emerging Markets ETFVWO10.73M0.01%162.3B USD0.06%$60.45+0.72%
Vanguard Total International Stock ETFVXUS9.57M0.00%646.2B USD0.05%$87.71+0.78%
iShares Core MSCI Emerging Markets ETFIEMG8.15M0.01%160B USD0.09%$81.57+0.64%
Avantis Emerging Markets Equity ETFAVEM5.65M0.02%27.89B USD0.33%$94.24+0.75%
State Street SPDR S&P Emerging Markets Dividend ETFEDIV3.93M0.32%1.23B USD0.49%$42.16+0.52%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS3.03M0.02%13.6B USD0.06%$160.06+0.43%
iShares Core MSCI Total International Stock ETFIXUS1.33M0.00%60.91B USD0.07%$97.945+0.76%
State Street SPDR Portfolio Emerging Markets ETFSPEM958.77K0.01%17.57B USD0.07%$52.38+0.61%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 10.73M
- Weight
- 0.01%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $60.45+0.72%
Vanguard Total International Stock ETFVXUS- Market value
- 9.57M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 8.15M
- Weight
- 0.01%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $81.57+0.64%
Avantis Emerging Markets Equity ETFAVEM- Market value
- 5.65M
- Weight
- 0.02%
- AUM
- 27.89B USD
- Expense ratio
- 0.33%
- Price / 1D
- $94.24+0.75%
State Street SPDR S&P Emerging Markets Dividend ETFEDIV- Market value
- 3.93M
- Weight
- 0.32%
- AUM
- 1.23B USD
- Expense ratio
- 0.49%
- Price / 1D
- $42.16+0.52%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 3.03M
- Weight
- 0.02%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.06+0.43%
iShares Core MSCI Total International Stock ETFIXUS- Market value
- 1.33M
- Weight
- 0.00%
- AUM
- 60.91B USD
- Expense ratio
- 0.07%
- Price / 1D
- $97.945+0.76%
State Street SPDR Portfolio Emerging Markets ETFSPEM- Market value
- 958.77K
- Weight
- 0.01%
- AUM
- 17.57B USD
- Expense ratio
- 0.07%
- Price / 1D
- $52.38+0.61%
Continue in GoAI
Research 2666.HKresearch.disclaimer





